CAS 105029-41-2

(2S)-N1-[(16S)-16,21-Diamino-21-imino-15-oxo-6,10,14,20-tetraazaheneicos-1-yl]-2-[[2-(2,4-dihydroxyphenyl)acetyl]amino]butanediamide

Description:

The chemical substance with the name "(2S)-N1-[(16S)-16,21-Diamino-21-imino-15-oxo-6,10,14,20-tetraazaheneicos-1-yl]-2-[[2-(2,4-dihydroxyphenyl)acetyl]amino]butanediamide" and CAS number "105029-41-2" is a complex organic compound characterized by its intricate structure, which includes multiple functional groups and a significant number of nitrogen atoms, indicative of its potential as a biologically active molecule. This compound features a tetraazaheneicos backbone, suggesting it may have applications in medicinal chemistry, particularly in the development of pharmaceuticals targeting specific biological pathways. The presence of amino and imino groups implies potential for hydrogen bonding and interactions with biological macromolecules, such as proteins or nucleic acids. Additionally, the dihydroxyphenylacetyl moiety may contribute to its solubility and reactivity, enhancing its pharmacological properties. Overall, this compound's unique structural features suggest it could be of interest in research related to drug design and development, particularly in the context of targeting diseases that involve complex biochemical interactions.

Formula: C₂₉H₅₂N₁₀O₆

InChI: InChI=1/C29H52N10O6/c30-22(7-4-15-38-29(32)33)27(44)36-16-6-13-35-12-5-11-34-10-2-1-3-14-37-28(45)23(19-25(31)42)39-26(43)17-20-8-9-21(40)18-24(20)41/h8-9,18,22-23,34-35,40-41H,1-7,10-17,19,30H2,(H2,31,42)(H,36,44)(H,37,45)(H,39,43)(H4,32,33,38)/t22-,23-/m0/s1

InChI key: InChIKey=FTNICLJXPYLDAH-GOTSBHOMSA-N

SMILES: C(C(N[C@H](C(NCCCCCNCCCNCCCNC([C@H](CCCNC(=N)N)N)=O)=O)CC(N)=O)=O)C1=C(O)C=C(O)C=C1

Synonyms:

• Butanediamide, N1-[(16S)-16,21-diamino-21-imino-15-oxo-6,10,14,20-tetraazaheneicos-1-yl]-2-[[(2,4-dihydroxyphenyl)acetyl]amino]-, (2S)-
• (2S)-N1-[(16S)-16,21-Diamino-21-imino-15-oxo-6,10,14,20-tetraazaheneicos-1-yl]-2-[[2-(2,4-dihydroxyphenyl)acetyl]amino]butanediamide
• N~1~-[5-({3-[(3-{[N~5~-(diaminomethylidene)-L-ornithyl]amino}propyl)amino]propyl}amino)pentyl]-N~2~-[(2,4-dihydroxyphenyl)acetyl]-L-aspartamide
• Butanediamide, N1-[(16S)-16,21-diamino-21-imino-15-oxo-6,10,14,20-tetraazaheneicos-1-yl]-2-[[2-(2,4-dihydroxyphenyl)acetyl]amino]-, (2S)-
• Argiopine
• Butanediamide, N1-(16,21-diamino-21-imino-15-oxo-6,10,14,20-tetraazaheneicos-1-yl)-2-[[(2,4-dihydroxyphenyl)acetyl]amino]-, [S-(R*,R*)]-
• (S)-N-[5-[[3-[[3-[[(S)-2-Amino-5-guanidino-1-oxopentyl]amino]propyl]amino]propyl]amino]pentyl]-2-[[(2,4-dihydroxyphenyl)acetyl]amino]succinamide
• ArgTX-636
• Arg-636
• N-[(1S,19S)-1-(2-Amino-2-oxoethyl)-2,18-dioxo-19-amino-22-guanidino-3,9,13,17-tetraazadocosane-1-yl]-(2,4-dihydroxyphenyl)acetamide

Argiotoxin 636

CAS: 105029-41-2

Argiotoxin 636 is a toxin and serves as a non-specific, non-competitive, and effective antagonist of ionotropic glutamate receptors (iGluR). It inhibits excitatory synaptic transmission in neurons and has paralyzing and muscle relaxant effects. Argiotoxin 636 can be utilized for research in neurological disorders.

Formula: C₂₉H₅₂N₁₀O₆

Color and Shape: Solid

Molecular weight: 636.79

Ref: TM-T203478